<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00256165</url>
  </required_header>
  <id_info>
    <org_study_id>CS04009TV</org_study_id>
    <nct_id>NCT00256165</nct_id>
  </id_info>
  <brief_title>REST Study: Left Ventricular Regression European Study</brief_title>
  <official_title>Left Ventricular Regression European Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain data regarding the left ventricular mass (LVM)&#xD;
      regression 6 months after the implant of an SJM Epic™ and SJM Epic™ Supra valve by comparing&#xD;
      LVM regression measured with magnetic resonance imaging (MRI) to LVM regression measured with&#xD;
      echocardiography (2-dimensional [2D] mandatory; 3-dimensional [3D] in sites where the&#xD;
      technology is available).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The comparison of left ventricular mass index (LVMI) at 6 months between echocardiogram (echo) and MRI in patients implanted with an Epic valve</measure>
    <time_frame>At 6 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tissue valve</intervention_name>
    <description>Aortic valve replacement</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient requires, for the first time, isolated aortic valve replacement due to aortic&#xD;
             stenosis or mixed aortic stenosis disease etiology when aortic stenosis is predominant&#xD;
             and aortic regurgitation is mild.&#xD;
&#xD;
          -  Patient is of legal age in the host country.&#xD;
&#xD;
          -  Patient (or legal guardian) has signed a study specific informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient was previously operated on with any heart surgery including heart valve&#xD;
             replacement or coronary artery bypass graft (CABG); or underwent any form of&#xD;
             myocardial revascularization in the past (including stents), etc.&#xD;
&#xD;
          -  Patient requires any concomitant heart surgery other than the isolated native aortic&#xD;
             heart valve replacement and concomitant ascending aortic replacement (e.g not allowed&#xD;
             are: multiple valve replacements or concomitant CABG, pacemaker insertions, or severe&#xD;
             septal hypertrophy needing surgical excision, etc.)&#xD;
&#xD;
          -  Patient has unstable angina&#xD;
&#xD;
          -  Patient is in New York Heart Association functional class IV&#xD;
&#xD;
          -  Patient has significant abnormality in wall motion&#xD;
&#xD;
          -  Patient is affected by active endocarditis.&#xD;
&#xD;
          -  Patient has a cardiac pacemaker or automatic implanted cardiac defibrillator&#xD;
&#xD;
          -  Patient is affected by acute aortic dissection.&#xD;
&#xD;
          -  Patient is in chronic and persistent atrial fibrillation&#xD;
&#xD;
          -  Patient receives hemodialysis therapy&#xD;
&#xD;
          -  Patient has a medical condition which contraindicates implantation of the SJM Epic and&#xD;
             Epic™ Supra Porcine Bioprosthetic Heart Valve (e.g. renal failure or abnormal calcium&#xD;
             metabolism).&#xD;
&#xD;
          -  Patient has aneurysmal clips or carotid artery vascular stents&#xD;
&#xD;
          -  Patient has a neurostimulator&#xD;
&#xD;
          -  Patient has an implanted or external drug infusion device (e.g. insulin pump)&#xD;
&#xD;
          -  Patient has a bone growth/fusion stimulator&#xD;
&#xD;
          -  Patient has a cochlear, otologic, or ear implant&#xD;
&#xD;
          -  Patients with severe claustrophobia in which medical sedation is contraindicated or&#xD;
             unable to resolve anxiety sufficiently&#xD;
&#xD;
          -  Patients with ocular foreign body (e.g. metal shavings)&#xD;
&#xD;
          -  Patient is pregnant or nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>G. Gerosa, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Universitario Cardiovasculare - Padua - Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Städtlishes Klinikum Braunschweig</name>
      <address>
        <city>Braunschweig</city>
        <zip>38126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>November 16, 2005</study_first_submitted>
  <study_first_submitted_qc>November 16, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2005</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <name_title>Christophe Bailleul</name_title>
    <organization>St. Jude Medical</organization>
  </responsible_party>
  <keyword>Aortic valve replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

